Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1α expression

British Journal of Anaesthesia

Volumn 106, Issue 4, 2011, Pages 590-599

  Yeh, C H ^a,b   Cho, W ^b   So, E C ^b   Chu, C C ^b   Lin, M C ^b   Wang, J J ^b   Hsing, C H ^b,c  

^a CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^b Chi Mei Medical Centre   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

acute lung injury; cytokines; hypoxia inducible factor 1 ; propofol; sepsis

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE DERIVED CHEMOKINE; MESSENGER RNA; PROPOFOL; PROTEIN BNIP3; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL TIME; UPREGULATION;

EID: 79952944394     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer005     Document Type: Article

References (37)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50 (Pubitemid 36056721)
2. Tsushima K, King LS, Aggarwal NR, et al. Acute lung injury review. Intern Med 2009; 48: 621-30
3. Bardales RH, Xie SS, Schaefer RF, Hsu SM. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996; 149: 845-52 (Pubitemid 26334168)
4. Marik PE. Propofol: Therapeutic indications and side-effects. Curr Pharm Des 2004; 10: 3639-49 (Pubitemid 39386579)
5. Marik PE. Propofol: An immunomodulating agent. Pharmacotherapy 2005; 25: 28S-33S (Pubitemid 40604876)
6. Li HH, Lin YC, Chen PJ, et al. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 2005; 153: 591-5
7. Wang B, Luo T, Chen D, Ansley DM. Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth Analg 2007; 105: 1027-33, table of contents (Pubitemid 47479317)
8. Wang L, Wu B, Sun Y, et al. Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation. Br J Anaesth 2010; 104: 606-12
9. Chu CH, David Liu D, Hsu YH, Lee KC, Chen HI. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulm Pharmacol Ther 2007; 20: 503-12 (Pubitemid 47077639)
10. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005; 100: 810-6, table of contents (Pubitemid 40300081)
11. Gao J, Zeng BX, Zhou LJ, Yuan SY. Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 2004; 92: 277-9 (Pubitemid 38159672)
12. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32 (Pubitemid 37328811)
13. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-4
14. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54 (Pubitemid 32972036)
15. Peyssonnaux C, Cejudo-Martin P, Doedens A, et al. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide- induced sepsis. J Immunol 2007; 178: 7516-9 (Pubitemid 46898018)
16. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002; 17: 463-7
17. Takabuchi S, Hirota K, Nishi K, et al. The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner. FEBS Lett 2004; 577: 434-8 (Pubitemid 39535326)
18. Tanaka T, Takabuchi S, Nishi K, et al. The intravenous anesthetic propofol inhibits lipopolysaccharide-induced hypoxia-inducible factor 1 activation and suppresses the glucose metabolism in macrophages. J Anesth 2010; 24: 54-60
19. Inoue K, Takano H, Shimada A, et al. Role of metallothionein in coagulatory disturbance and systemic inflammation induced by lipopolysaccharide in mice. FASEB J 2006; 20: 533-5 (Pubitemid 46671240)
20. Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol 2007; 29: 477-86 (Pubitemid 350261185)
21. Inada T, Asai T, Yamada M, Shingu K. Propofol and midazolam inhibit gastric emptying and gastrointestinal transit in mice. Anesth Analg 2004; 99: 1102-6, table of contents (Pubitemid 39287400)
22. Irifune M, Sugimura M, Takarada T, et al. Propofol anaesthesia in mice is potentiated by muscimol and reversed by bicuculline. Br J Anaesth 1999; 83: 665-7 (Pubitemid 29458839)
23. Hsing CH, Chiu CJ, Chang LY, Hsu CC, Chang MS. IL-19 is involved in the pathogenesis of endotoxic shock. Shock 2008; 29: 7-15
24. Sumbayev VV. LPS-induced Toll-like receptor 4 signalling triggers cross-talk of apoptosis signal-regulating kinase 1 (ASK1) and HIF-1alpha protein. FEBS Lett 2008; 582: 319-26
25. Nishi K, Oda T, Takabuchi S, et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal 2008; 10: 983-95 (Pubitemid 351301367)
26. Luo F, Liu X, Yan N, et al. Hypoxia-inducible transcription factor-1 alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway. BMC Cancer 2006; 6: 26
27. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 2002; 30: 904-7 (Pubitemid 34297816)
28. Marik PE, Zaloga GP. Therapeutic sedation: Has its time come? Crit Care Med 2002; 30: 949-52 (Pubitemid 34297834)
29. Basu S, Mutschler DK, Larsson AO, et al. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001; 50: 341-8 (Pubitemid 32913280)
30. Yu HP, Lui PW, Hwang TL, Yen CH, Lau YT. Propofol improves endothelial dysfunction and attenuates vascular superoxide production in septic rats. Crit Care Med 2006; 34: 453-60
31. Clerici C, Planes C. Gene regulation in the adaptive process to hypoxia in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009; 296: L267-74
32. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. Review: Hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions. J Interferon Cytokine Res 2005; 25: 297-310 (Pubitemid 40911381)
33. Nagata T, Kansha M, Irita K, Takahashi S. Propofol inhibits FMLP-stimulated phosphorylation of p42 mitogen-activated protein kinase and chemotaxis in human neutrophils. Br J Anaesth 2001; 86: 853-8 (Pubitemid 32514901)
34. Kasuno K, Takabuchi S, Fukuda K, et al. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 2004; 279: 2550-8 (Pubitemid 38114240)
35. Jantsch J, Chakravortty D, Turza N, et al. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharideinduced dendritic cell activation and function. J Immunol 2008; 180: 4697-705
36. Ray R, Chen G, Vande Velde C, et al. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 2000; 275: 1439-48 (Pubitemid 30051204)
37. Vande Velde C, Cizeau J, Dubik D, et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20: 5454-68 (Pubitemid 30482883)